For example, models such as the GFAP-IL6 mouse, which overexpress interleukin-6 (IL-6) in astrocytes, exhibit progressive neurodegeneration and cognitive decline, making them valuable models for studying the effects of neuroinflammation on AD progression [239]. Here, GFAP is linked to Alzheimer disease.